Literature DB >> 17375702

Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy.

J Metindir1, G Bilir.   

Abstract

OBJECTIVE: This study was performed to identfy surgical and histopathologic prognostic factors that could predict 5-year disease-free survival (DFS) after patients underwent radical hysterectomy and pelvic-paraaortic lymphadenectomy for FIGO Stage I-II cervical carcinoma.
METHODS: A retrospective review was performed for all patients undergoing primary radical hysterectomy and pelvic-paraaortic lymphadenectomy for Stage I-II cervical cancer at Ankara Oncology Hospital from 1995 to 2000. Clinical and pathologic variables including age, tumor size (TS), clinical stage, depth of invasion (DI), lymphovascular space involvement (LVSI), cell type, tumor grade, lymph node metastases (LNM), parametrial involvement, surgical margin involvement and pattern of adjuvant therapy were analyzed using univariate analyses. DFS was performed by the Kaplan-Meier method and the log-rank test. Independent prognostic and predictive factors affecting DFS were assessed by the Cox proportional hazard method.
RESULTS: Ninety-three patients underwent primary type III radical hysterectomy and pelvic-paraaortic lymphadenectomy. Five-year DFS was 87.1%. LVSI, parametrial involvement and grade were the prognostic factors that independently affected survival. DFS was not significantly different for age, disease status of the surgical margins, tumor size, depth of invasion, cell type, pelvic lymph node metastases and adjuvant radiotherapy.
CONCLUSIONS: LVSI, parametrial invasion and histologic grade 2-3 were independent prognostic factors in early-stage cervical cancer patients. Adjuvant radiotherapy in these patients provides no survival advantage.

Entities:  

Mesh:

Year:  2007        PMID: 17375702

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Value of pelvic examination and imaging modality for the evaluation of tumor size in cervical cancer.

Authors:  Yoo-Kyung Lee; Seung-Su Han; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

2.  Treatment Outcomes of Early Carcinoma Cervix Before and After Sub-specialization.

Authors:  Vinotha Thomas; Rachel G Chandy; Ajit Sebastian; Anitha Thomas; Dhanya S Thomas; Thomas S Ram; Abraham Peedicayil
Journal:  Indian J Surg Oncol       Date:  2020-09-28

3.  Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery.

Authors:  Thea Laurentius; Annelore Altendorf-Hofmann; Oumar Camara; Ingo B Runnebaum; Thomas G Wendt
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-15       Impact factor: 4.553

4.  Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients.

Authors:  Abida Abudukadeer; Rania Bakry; Georg Goebel; Irene Mutz-Dehbalaie; Andreas Widschwendter; Günther K Bonn; Heidi Fiegl
Journal:  Int J Mol Sci       Date:  2012-07-05       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.